Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.
Ziermann R, Celis L, Derdelinckx I, Lambert C, Veeck J, Rizzo MG, Vanderborght B, Zissis G, Clumeck N, Fransen K, Vaira D, Hendricks D, Van Laethem K, Vandamme AM, Schmit JC, Knechten H, De Luca A, Louwagie J, Segers P, De Boeck K, Pottel H, De Brauwer A, Hulstaert F. Ziermann R, et al. Among authors: lambert c. J Clin Virol. 2004 Dec;31 Suppl 1:S7-15. doi: 10.1016/j.jcv.2004.09.014. J Clin Virol. 2004. PMID: 15567089 Free article.
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.
Ruelle J, Roman F, Vandenbroucke AT, Lambert C, Fransen K, Echahidi F, Piérard D, Verhofstede C, Van Laethem K, Delforge ML, Vaira D, Schmit JC, Goubau P. Ruelle J, et al. Among authors: lambert c. BMC Infect Dis. 2008 Feb 27;8:21. doi: 10.1186/1471-2334-8-21. BMC Infect Dis. 2008. PMID: 18304321 Free PMC article.
Longitudinal use of a line probe assay for human immunodeficiency virus type 1 protease predicts phenotypic resistance and clinical progression in patients failing highly active antiretroviral therapy.
Servais J, Lambert C, Plesséria JM, Fontaine E, Robert I, Arendt V, Staub T, Hemmer R, Schneider F, Schmit JC. Servais J, et al. Among authors: lambert c. Antimicrob Agents Chemother. 2002 Jun;46(6):1928-33. doi: 10.1128/AAC.46.6.1928-1933.2002. Antimicrob Agents Chemother. 2002. PMID: 12019110 Free PMC article.
Impact on replicative fitness of the G48E substitution in the protease of HIV-1: an in vitro and in silico evaluation.
Zimmer JM, Roman F, Lambert C, Jonckheer A, Vazquez A, Plesséria JM, Servais JY, Covens K, Weber J, Van Laethem K, Schmit JC, Vandamme AM, Quinones-Mateu ME, De Maeyer M. Zimmer JM, et al. Among authors: lambert c. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):255-62. doi: 10.1097/QAI.0b013e318174dca6. J Acquir Immune Defic Syndr. 2008. PMID: 18545158
HIV-1 subtypes in Luxembourg, 1983-2000.
Deroo S, Robert I, Fontaine E, Lambert C, Plesséria JM, Arendt V, Staub T, Hemmer R, Schneider F, Schmit JC. Deroo S, et al. Among authors: lambert c. AIDS. 2002 Dec 6;16(18):2461-7. doi: 10.1097/00002030-200212060-00012. AIDS. 2002. PMID: 12461421
Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
Servais J, Lambert C, Fontaine E, Plesséria JM, Robert I, Arendt V, Staub T, Schneider F, Hemmer R, Burtonboy G, Schmit JC. Servais J, et al. Among authors: lambert c. J Clin Microbiol. 2001 Feb;39(2):454-9. doi: 10.1128/JCM.39.2.454-459.2001. J Clin Microbiol. 2001. PMID: 11158089 Free PMC article.
Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains.
Roman F, Gonzalez D, Lambert C, Deroo S, Fischer A, Baurith T, Staub T, Boulmé R, Arendt V, Schneider F, Hemmer R, Schmit JC. Roman F, et al. Among authors: lambert c. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):134-9. doi: 10.1097/00126334-200306010-00003. J Acquir Immune Defic Syndr. 2003. PMID: 12794544
2,267 results